Albert Health key facts
as of Oct 2026- Developer of an evidence-based multi-chronic disease management platform designed to help patients take the right dose of medicine at the right time.
- Albert Health is valued at approximately $4.6M as of Oct 2026 (last reported valuation).
- It has raised $3.0M; the latest was Accelerator/Incubator in Jan 2019.
- Notable investors include Techstars, Turkey Development Fund, Maxis Private Equity Portfolio Management, Türk Telekom Ventures, Eksim Venture — 23 tracked in total.
- Status: Privately Held (backing).
Albert Health's last reported valuation, Jun 2022. Nothing priced has surfaced since.
- ·The complete investor list: 23 names
- ·Watch Albert Health: the Monday email on marks, rounds and moves
Albert Health funding rounds
No funding rounds for Albert Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Albert Health
23+Albert Health valuation
Albert Health's last reported valuation was $4.6 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.
Albert Health investors
23 investors are on record for Albert Health, including Techstars, Turkey Development Fund, Maxis Private Equity Portfolio Management and Türk Telekom Ventures.
About Albert Health
Developer of an evidence-based multi-chronic disease management platform designed to help patients take the right dose of medicine at the right time. The company's platform leverages artificial intelligence to provide medication reminders and records, track health measurements, and warn about adverse drug events, enabling patients to manage medications while sharing data with doctors and letting families monitor treatment.
- Sector
- Healthcare
- HQ
- Istanbul, Turkey
- Founded
- 2018
- Employees
- 24
- Website
- albert.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.